nach oben

American Journal of Clinical Dermatology

Erschienen in:

01.06.2017 | Therapy in Practice

Increasing Adherence with Topical Agents for Atopic Dermatitis

verfasst von: Nupur U. Patel, Veronica D’Ambra, Steven R. Feldman

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Atopic dermatitis (AD) is an intensely pruritic dermatosis that develops most commonly during early infancy and childhood and may follow a chronic, relapsing course into adulthood. As a chronic disease, AD requires treatment over an extended period of time, and is therefore difficult to treat. The main difficulty stems from poor adherence to treatment by patients for reasons such as frustration with medication efficacy, inconvenience, and fear of side effects. Methods that improve adherence include creating therapeutic plans with patient preferences in mind, early follow-up visit, increasing patient education through workshops, and discussing with patients and their caretakers their fears about treatment methods. AD can be exceedingly detrimental to a patient’s quality of life. Simple measures to improve adherence may improve patients’ treatment outcomes and quality of life.

Admani S, Eichenfield LF. Atopic dermatitis. In: Lebwohl M, et al., editors. Treatment skin disease. 4th ed. Philadelphia, PA: Elsevier Ltd; 2014. p. 52–60.

Brown SJ, Relton CL, Liao H, Zhao Y, Sandilands A, Wilson IJ, et al. Filaggrin null mutations and childhood atopic eczema: a population-based case-control study. J Allergy Clin Immunol. 2008;121(–46):940–946.e3.CrossRefPubMed

Williams H, Stewart A, von Mutius E, Cookson W, Ross Anderson H, International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups. Is eczema really on the increase worldwide? J Allergy Clin Immunol. 2008;121:947–54.CrossRefPubMed

Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol. 2014;150:593–600.CrossRefPubMedPubMedCentral

Boguniewicz M, Leung D. Atopic dermatitis. In: Adkinson F, et al., editors. Middleton’s allergy: principles and practice. 8th ed. Philadelphia: Saunders; 2014. p. 540–64.

Kubota Y, Yoneda K, Nakai K, Katsuura J, Moriue T, Matsuoka Y, et al. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study. J Am Acad Dermatol. 2009;60:212–7.CrossRefPubMed

Bass AM, Anderson KL, Feldman SR. Interventions to increase treatment adherence in pediatric atopic dermatitis: a systematic review. J Clin Med. 2015;4:231–42.CrossRefPubMedPubMedCentral

Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56:211–6.CrossRefPubMed

Chakrabarti S. What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry. 2014;4:30–6.CrossRefPubMedPubMedCentral

10.

Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55:607–13.CrossRefPubMed

11.

Kelsay K, Klinnert M, Bender B. Addressing psychosocial aspects of atopic dermatitis. Immunol Allergy Clin North Am. 2010;30:385–96.CrossRefPubMed

12.

Richards HL, Fortune DG, O’Sullivan TM, Main CJ, Griffiths CEM. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 1999;41(4):581–3.PubMed

13.

World Health Organization. Adherence to long term therapies: evidence for action. Geneva: World Health Organization; 2003.

14.

Hix E, Gustafson CJ, O’Neill JL, Huang K, Sandoval LF, Harrison J, et al. Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis. Dermatol Online J. 2013;19:20029.PubMed

15.

Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51:212–6.CrossRefPubMed

16.

Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27–33.CrossRefPubMed

17.

Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol. 2010;9:324–9.PubMed

18.

Ellis RM, Koch LH, McGuire E, Williams JV. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol. 2011;28:242–4.CrossRefPubMed

19.

Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142:931–6.CrossRefPubMed

20.

Fischer G. Compliance problems in paediatric atopic eczema. Australas J Dermatol. 1996;37(Suppl 1):S10–3.CrossRefPubMed

21.

Surber C, Itin PH, Bircher AJ, Maibach HI. Topical corticosteroids. J Am Acad Dermatol. 1995;32:1025–30.CrossRefPubMed

22.

David TJ. Steroid scare. Arch Dis Child. 1987;62:876–8.CrossRefPubMedPubMedCentral

23.

Hon K-LE, Kam W-YC, Leung T-F, Lam M-CA, Wong K-Y, Lee K-CK, et al. Steroid fears in children with eczema. Acta Paediatr. 2006;95:1451–5.CrossRefPubMed

24.

Lee JY, Her Y, Kim CW, Kim SS. Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol. 2015;27:499–506.CrossRefPubMedPubMedCentral

25.

Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy AM, Nguyen JM, Leux C, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165:808–14.CrossRefPubMed

26.

Beattie PE, Lewis-Jones MS. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol. 2003;28:549–53.CrossRefPubMed

27.

Halling-Overgaard A-S, Kezic S, Jakasa I, Engebretsen KA, Maibach H, Thyssen JP. Skin absorption through atopic dermatitis skin: a systematic review. Br J Dermatol. 2016. doi:10.1111/bjd.15065.PubMed

28.

Santer M, Muller I, Yardley L, Lewis-Jones S, Ersser S, Little P. Parents’ and carers’ views about emollients for childhood eczema: qualitative interview study. BMJ Open. 2016;6:e011887.CrossRefPubMedPubMedCentral

29.

Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149:582–9.CrossRefPubMed

30.

Siegfried EC, Jaworski JC, Kaiser JD, Hebert AA. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr. 2016;16:75.CrossRefPubMedPubMedCentral

31.

Sagransky MJ, Yentzer BA, Williams LL, Clark AR, Taylor SL, Feldman SR. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010;146:1428–30.CrossRefPubMed

32.

Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71:116–32.CrossRefPubMedPubMedCentral

33.

Dabade TS, Davis DMR, Wetter DA, Hand JL, McEvoy MT, Pittelkow MR, et al. Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic. J Am Acad Dermatol. 2012;67:100–6.CrossRefPubMed

34.

Chong M, Fonacier L. Treatment of eczema: corticosteroids and beyond. Clin Rev Allergy Immunol. 2016;51:249–62.CrossRefPubMed

35.

Andersen R, Thyssen J, Maibach H. The role of wet wrap therapy in skin disorders: a literature review. Acta Derm Venereol. 2014;95:933–9.CrossRef

36.

Oranje A, Devillers A, Kunz B, Jones S, DeRaeve L, Van Gysel D, et al. Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel’s opinion and review of the literature. J Eur Acad Dermatol Venereol. 2006;20:1277–86.CrossRefPubMed

37.

Rork JF, Sheehan WJ, Gaffin JM, Timmons KG, Sidbury R, Schneider LC, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148:391–2.CrossRefPubMedPubMedCentral

38.

Staab D, von Rueden U, Kehrt R, Erhart M, Wenninger K, Kamtsiuris P, et al. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol. 2002;13:84–90.CrossRefPubMed

39.

Moore EJ, Williams A, Manias E, Varigos G, Donath S. Eczema workshops reduce severity of childhood atopic eczema. Australas J Dermatol. 2009;50:100–6.CrossRefPubMed

40.

Grillo M, Gassner L, Marshman G, Dunn S, Hudson P. Pediatric atopic eczema: the impact of an educational intervention. Pediatr Dermatol. 2006;23:428–36.CrossRefPubMed

41.

Shaw M, Morrell DS, Goldsmith LA. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD). Pediatr Dermatol. 2008;25:19–24.CrossRefPubMed

42.

Chinn DJ, Poyner T, Sibley G. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Br J Dermatol. 2002;146:432–9.CrossRefPubMed

43.

Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006;7:231–6.CrossRefPubMed

44.

Ersser SJ, Cowdell F, Latter S, Gardiner E, Flohr C, Thompson AR, Jackson K, Farasat H, Ware F, Drury A. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev. 2014;(1):CD004054. doi:10.1002/14651858.CD004054.pub3.

45.

Long CC, Funnell CM, Collard R, Finlay AV. What do members of the National Eczema Society really want? Clin Exp Dermatol. 1993;18:516–22.CrossRefPubMed

46.

Broberg A, Kalimo K, Lindblad B, Swanbeck G. Parental education in the treatment of childhood atopic eczema. Acta Derm Venereol. 1990;70:495–9.PubMed

47.

Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57:81–3.CrossRefPubMed

48.

Feldman SR. The parable of the piano teacher. Dermatologist. 2007;15(8).

49.

van Os-Medendorp H, Koffijberg H, Eland-de Kok PCM, van der Zalm A, de Bruin-Weller MS, Pasmans SGMA, et al. E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training. Br J Dermatol. 2012;166:1060–8.CrossRefPubMed

50.

Evangelista MTP, Abad-Casintahan F, Lopez-Villafuerte L. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial. Int J Dermatol. 2014;53:100–8.CrossRefPubMed

51.

Canpolat F, Erkoçoğlu M, Tezer H, Kocabaş CN, Kandi B. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age: a randomized double blind pilot trial. Eur Rev Med Pharmacol Sci. 2012;16:1989–93.PubMed

52.

Eisen D, Ellis CN, Duell EA, Griffiths CE, Voorhees JJ. Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med. 1990;323:290–4.CrossRefPubMed

53.

Happonen HP, Lassus A, Santalahti J, Forsström S, Lassus J. Topical idoxuridine for treatment of genital warts in males. A double-blind comparative study of 0.25% and 0.5% cream. Genitourin Med. 1990;66:254–6.PubMedPubMedCentral

54.

Feldman SR. Tachyphylaxis to topical corticosteroids: the more you use them, the less they work? Clin Dermatol. 2006;24:229–30.CrossRefPubMed

55.

Van Der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br J Dermatol. 1999;140:1114–21.

56.

Kojima R, Fujiwara T, Matsuda A, Narita M, Matsubara O, Nonoyama S, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30:29–35.CrossRefPubMed

57.

Ohya Y, Williams H, Steptoe A, Saito H, Iikura Y, Anderson R, et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol. 2001;117:852–7.CrossRefPubMed

58.

Fenerty SD, O’Neill JL, Gustafson CJ, Feldman SR. Maternal adherence factors in the treatment of pediatric atopic dermatitis. JAMA Dermatol. 2013;149:229–31.CrossRefPubMed

59.

Santer M, Burgess H, Yardley L, Ersser SJ, Lewis-Jones S, Muller I, et al. Managing childhood eczema: qualitative study exploring carers’ experiences of barriers and facilitators to treatment adherence. J Adv Nurs. 2013;69:2493–501.PubMed

60.

Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005;22:192–9.CrossRefPubMed

Titel: Increasing Adherence with Topical Agents for Atopic Dermatitis
verfasst von: Nupur U. Patel
Veronica D’Ambra
Steven R. Feldman
Publikationsdatum: 01.06.2017
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology / Ausgabe 3/2017
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.1007/s40257-017-0261-5

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Increasing Adherence with Topical Agents for Atopic Dermatitis

Abstract

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment

Stasis Dermatitis: Pathophysiology, Evaluation, and Management

Perianal Lesions in Children: An Updated Review

Poisoning Through Pediatric Skin: Cases from the Literature

Tranexamic Acid in the Treatment of Melasma: A Review of the Literature

Biological Therapy of Refractory Ulcerative Oral Lichen Planus with Plasma Rich in Growth Factors

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie